| Financial Year |
March 31 2023 |
| Monetary Funds |
435,118,400.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
134,687,606.70 |
| Accounts Receivable |
1,678,210,824.23 |
| Advances to Suppliers |
220,168,986.07 |
| Other Receivables |
62,642,027.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,723,349,903.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
66,964,644.18 |
| Total Current Assets |
4,401,837,503.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
70,174,971.82 |
| Investment Properties |
174,183,604.08 |
| Fixed Assetes |
280,410,661.93 |
| Under-construction Projects |
128,567,739.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
345,865,469.94 |
| R&D expenses |
26,371,895.87 |
| Goodwill |
646,484,109.18 |
| Long-Term Deferred and Prepaid Expenses |
6,541,985.05 |
| Deferred Income Tax Assets |
79,585,742.48 |
| Other Non-Current Assets |
24,795,834.20 |
| Sub-Total of Non-Current Assets |
1,908,810,978.14 |
| Total Assets |
6,310,648,481.57 |
| Short-Term Loans |
2,066,731,631.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
98,930,597.94 |
| Accounts Received In Advance |
5,738,736.73 |
| Employee Compensation Payable |
20,246,091.80 |
| Taxes Payable |
28,040,029.95 |
| Interest Payable |
-- |
| Dividend Payable |
1,192.80 |
| Other payables |
39,101,603.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,930,569.04 |
| Other Current Liabilities |
39,147,145.89 |
| Sub-Total of Current Liabilities |
2,643,582,672.10 |
| Long-term Loans |
79,780,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,155,748.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
106,921,634.48 |
| Total Liabilities |
2,750,504,306.58 |
| Paid-In Capital(Or Share Stock) |
637,744,672.00 |
| Capital Surplus |
1,473,514,845.48 |
| Surplus Reserve |
96,441,807.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,078,104,081.41 |
| Minority Stockholder's Interest |
259,174,786.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,300,969,388.22 |
| Owner's Equity（Stockholder's Equity） |
3,560,144,174.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,310,648,481.57 |
